Regeneron Pharmaceuticals · Cash & Short-Term Investments

Latest reported$8.61Bperiod endingDec 31, 2025

REGN FY Cash & Short-Term Investments ($21.80M → $8.61B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

REGN cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	8,605,200,000
Dec 31, 2024	9,012,500,000
Dec 31, 2023	10,844,800,000
Dec 31, 2022	7,742,300,000
Dec 31, 2021	5,694,700,000
Dec 31, 2020	3,587,000,000
Dec 31, 2019	3,214,300,000
Dec 31, 2018	2,809,900,000
Dec 31, 2017	1,409,500,000
Dec 31, 2016	1,038,684,000
Dec 31, 2015	1,045,223,000
Dec 31, 2014	900,480,000
Dec 31, 2013	693,984,000
Dec 31, 2012	308,095,000
Dec 31, 2011	526,942,000
Dec 31, 2010	249,368,000
Dec 31, 2009	341,330,000
Dec 31, 2008	474,750,000
Dec 31, 2007	766,457,000
Dec 31, 2006	459,276,000
Dec 31, 2005	298,545,000
Dec 31, 2004	295,982,000
Dec 31, 2003	293,774,000
Dec 31, 2002	264,271,000
Dec 31, 2001	385,079,000
Dec 31, 2000	117,612,000
Dec 31, 1999	66,200,000
Dec 31, 1998	19,800,000
Dec 31, 1997	28,900,000
Dec 31, 1996	34,500,000
Dec 31, 1995	32,700,000
Dec 31, 1994	23,600,000
Dec 31, 1993	12,500,000
Dec 31, 1992	16,400,000
Dec 31, 1991	26,200,000
Dec 31, 1990	21,800,000